Clarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Total Revenue

Revenue analysis for CRXT.

Quarterly Revenue

$4.05M

↑ 45.74% YoY

As of Jun 2022

Annual Revenue (TTM)

$19.24M

↑ 284.55% YoY

Trailing 12 months ending Jun 2022

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin